Non-alcoholic fatty liver disease (NAFLD) is regarded as a manifestation of metabolic syndrome in the liver.
非酒精性脂肪肝被认为是肝的代谢综合症的表现。
That is the fat that can cause all the complications of metabolic syndrome, including nonalcoholic fatty liver disease.
这种脂肪能引起代谢综合征相关并发症，包括非酒精性脂肪肝。
ObjectiveTo evaluate the therapeutic effect of Danning Tablet (DNT) on patients with non-alcoholic fatty liver (NAFL) of damp-heat Syndrome type.
目的评价胆宁片治疗非酒精性脂肪性肝病（湿热型）的临床疗效。
Fatty liver disease (FLD) is a clinicopathological syndrome caused by a variety of reasons. The main lesions are in hepatic lobule with steatohepatitis and accumulation of triglycerides in the liver.
脂肪性肝病是多种原因引起的病变主体在肝小叶、以肝细胞脂肪变性和脂肪蓄积过多为主的临床病理综合征。
Fatty liver disease (FLD) is a clinical pathological syndrome characterized by unusual fat storing in liver cells with many causes.
脂肪性肝病(简称脂肪肝)是一种多病因引起的以肝细胞内中性脂肪异常沉积为主的临床病理综合征。
Objective to investigate the relationship between metabolic syndrome (MS) and nonalcoholic fatty liver disease (NAFLD) in non-obese impaired glucose tolerant (IGT) subjects.
目的探讨非肥胖的糖耐量受损(igt)者的非酒精性脂肪性肝病(NAFLD)与代谢综合征(MS)的关系。
Objective To study the clinical effect of hemodialysis (HD) plus hemoperfusion (HP) on the patients of acute fatty liver of pregnancy (AFLP) associated with multiple organ dysfunction syndrome (MODS).
目的观察血液透析联合血液灌流治疗妊娠急性脂肪肝(AFLP)并发多脏器功能障碍综合征(MODS)的疗效。
Nonalcoholic fatty liver disease (NAFLD) has been consistently found to be associated with features of the metabolic syndrome (MS), a condition carrying a high risk of cardiovascular events.
研究表明，脂肪性肝病使血管壁从解剖学和功能上都发生了较大改变，检测该病对筛查高风险心血管疾病患儿有极为重要的临床意义。
Nonalcoholic fatty liver disease (NAFLD) has been consistently found to be associated with features of the metabolic syndrome (MS), a condition carrying a high risk of cardiovascular events.
研究表明，脂肪性肝病使血管壁从解剖学和功能上都发生了较大改变，检测该病对筛查高风险心血管疾病患儿有极为重要的临床意义。
应用推荐